Stock listing

NASDAQ:IMPL Impel Neuropharma Inc Stock

Follow Impel Neuropharma Inc into a list and get an email when it puts out news.

Delisted NASDAQ:IMPL no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:IMPL
Asset type
Stock
Exchange
NASDAQ
Currency
USD

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Adrian Adams
Other companies: Akebia Therapeutics, Inc. (Chairperson · Since at least Dec 12, 2018); Talphera, Inc. (Director · Since at least Feb 11, 2013); Aralez Pharmaceuticals Inc (Chief Executive Officer, Director · Feb 5, 2016 – May 11, 2017 · Past); POZEN Inc (Chief Executive Officer, Director · May 31, 2015 – Nov 11, 2015 · Past); Auxilium Pharmaceuticals Inc (CEO and President, Director · Dec 7, 2011 – Jan 29, 2015 · Past); Inspire Pharmaceuticals Inc (President and CEO, Director · Feb 22, 2010 – May 13, 2011 · Past); Amylin Pharmaceuticals LLC (Director · Oct 29, 2007 – Aug 8, 2012 · Past); Sepracor Inc (President & CEO, Director · Mar 1, 2007 – Oct 20, 2009 · Past); Neurocrine Biosciences, Inc. (Director · Jun 30, 2006 – Jun 30, 2006 · Past); Kos Pharmaceuticals Inc (President & CEO, Director · Jan 26, 2006 – Dec 13, 2006 · Past)
COB, CEO and President, Director · Apr 22, 2021 – Jan 26, 2022 · Past
John Leaman
Other companies: Traws Pharma, Inc. (Director · Since at least Oct 1, 2025); Cartesian Therapeutics, Inc. (CFO, Treas. & Hd Corp Strategy · Oct 26, 2017 – Jun 15, 2018 · Past)
Chief Fin. & Business Officer · Apr 22, 2021 – Jan 26, 2022 · Past
David D Allison
Other companies: CinCor Pharma Inc (Director · Jan 6, 2022 – Feb 24, 2023 · Past)
Director · Apr 22, 2021 – Jul 11, 2021 · Past
John HoekmanChief Scientific Officer · Apr 22, 2021 – Jan 26, 2022 · Past
Leonard PaolilloChief Commercial Officer · Apr 22, 2021 – Jan 26, 2022 · Past
Stephen B ShrewsburyChief Medical Officer · Apr 22, 2021 – Mar 29, 2022 · Past

Open People

Log in to ask 6ix AI your own questions about Impel Neuropharma Inc.